#clinical trial

Thin Graphene Oxide Nanosheets Safe for Human Inhalation in First Controlled Clinical Trial

Thin Graphene Oxide Nanosheets Safe for Human Inhalation in First Controlled Clinical Trial

Revolutionary Neupulse Device Successfully Reduces Tics in Clinical Trials for Tourette’s Syndrome

Revolutionary Neupulse Device Successfully Reduces Tics in Clinical Trials for Tourette’s Syndrome